Akihito Kawazoe

15PUBLICATIONS
113CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 21, 2026
A cDC1-NK/T-Malignant Cell Circuit Drives Immunogenic Remodeling Under PD-1 Blockade in Gastric Cancer.

|May 21, 2026
Neutrophil-Macrophage Interactions Shape Inflammatory Macrophage Remodeling in Gastric Cancer During Chemo-Immunotherapy.

|Apr 27, 2026
Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation.

|Jan 06, 2026
A Phase III study of perioperative dostarlimab in patients with dMMR/MSI-H resectable colon cancer: AZUR-2 study design.

Naureen Starling, Elena Elez, John H Strickler

|Jul 06, 2025
ONO-4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.

Akihito Kawazoe, Kensei Yamaguchi, Tetsuya Hamaguchi

|Jun 02, 2025
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer.

Yelena Y Janjigian, Salah-Eddin Al-Batran, Zev A Wainberg

Pageof 3

Frequent Collaborators

10 joint publications

Kohei Shitara

5 joint publications

Hiroyoshi Nishikawa

4 joint publications

Shohei Koyama

3 joint publications

Takayuki Yoshino